ملخصات الابحاث

المجالات البحثية

Chitosan–sulfonic acid-catalyzed green synthesis of naphthalene-based azines as potential anticancer agents
Design and synthesis of novel hybrids incorporating thiadiazole or thiazole-naphthalene: Anticancer assessment and molecular docking study
Efficient green synthesis of hydrazide derivatives using L-proline: Structural characterization, anticancer activity, and molecular docking studies
Green Biocatalyst for Ultrasound-Assisted Thiazole Derivatives: Synthesis, Antibacterial Evaluation, and Docking Analysis
Green route synthesis and molecular docking of azines using cellulose sulfuric acid under microwave irradiation
Green synthesis and molecular docking study of some new thiazoles using terephthalohydrazide chitosan hydrogel as ecofriendly biopolymeric catalyst
Green synthesis of hydrazono-thiazolones using vitamin B1 and their antibacterial implications

الابحاث العلمية

1 - Synthesis, docking, SAR and ADMET evaluation of novel pyrrolo[3,4-c]pyrazole-4,6-dione derivatives (2026).

2 - Synthesis and Biological Evaluation of Thiazolyl–Pyrimidine Hybrids as Potential Antiproliferative Agents with Molecular Docking Insights (2025).

3 - Novel bis-Thiazolidinone -based chalcones with pyridine linker: Eco-friendly synthesis, cholinesterase and beta-amyloid inhibition potency, and molecular docking studies (2025).

4 - Synthesis of Pyrido[2,3-d]Azolopyrimidinones: Design and Epidermal Growth Factor Receptor-Targeted Molecular Docking Toward Novel Anticancer Leads (2025).

5 - Novel pyrimidinone scaffolds synthesized via nanotechnology as promising inhibitors of the hepatitis A virus with computational analyses (2025).

6 - Benzimidazotriazines as adenosine receptor-targeting anticancer agents: Synthesis, cytotoxicity, DFT, and docking studies (2025).

7 - Design, Synthesis, Cytotoxicity Assessment, and Molecular Docking of Novel Triazolopyrimidines as Potent Cyclin-Dependent Kinase 4 Inhibitors (2025).

8 - Synthesis, in silico and in vitro studies of aminopyrimidine hybrids as EGFR TK inhibitors and anti-proliferative agents (2025).

9 - Antiplatelet therapy through inhibition of P2Y12 and phosphodiesterase receptors by novel synthesis 1,3-dicyclohexylpyrimidine-2,4(1H,3H)-dione derivatives with computational evaluation (2025).

10 - Novel guanidine derivatives as mechanistic scaffolds for anticancer agents: synthesis, characterization, DNA-binding, and computational studies (2025).

11 - Biological evaluation and molecular docking studies of novel aza-acyclic nucleosides as putative antimicrobial, anticancer, and antioxidant agents (2025).

12 - Synthesis, Anticancer Evaluation, and Molecular Docking of Novel Thiazolobenzimidazole–Thiazole Hybrids as Potent Colon Cancer Inhibitors (2025).

13 - Design and Evaluation of Novel Benzimidazolo-Triazole-Tetrazole Derivatives as Anticancer Agents Against MCF-7 Cells (2025).

14 - Design, Synthesis, and Biological Assessment of Bis-thiazole Derivatives as Promising Anticancer Agents with Molecular Docking Insights (2025).

15 - Synthesis of Bis-Pyrimidothiazine and Bis-Pyrimidothiadiazinone derivatives as VEGFR2/KDR inhibitors via Michael and Mannich reactions (2025).

16 - A Novel Series of Benzimidazole-Triazole-Tetrazole Compounds: Synthesis, Structural Analysis, and Cytotoxic Activity Against MCF-7 Cells (2025).

17 - Benzimidazole chemistry in oncology: recent developments in synthesis, activity, and SAR analysis (2025).

18 - Innovative Pivaloyl Fixed 1,3-Thiazole-2-imines as Multitarget Inhibitors: Synthesis, Enzyme Inhibition, Molecular Docking and Structure Activity Relationship (SAR) Studies (2025).

19 - Ascorbic acid exhibits more of a protective effect than estradiol against nephrotoxicity induced by malathion in rats: a histopathological and molecular docking study (2025).

20 - Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents (2025).

21 - Novel thiazolyl-pyrimidine derivatives as potential anticancer agents: Synthesis, biological evaluation, and molecular docking studies (2024).

22 - Synthesis, characterization, and in silico studies of substituted 2,3-dihydro-1,3,4-thiadiazole derivatives (2024).

23 - Corrigendum to “Synthesis, molecular docking study, and biological evaluation and of new thiadiazole and thiazole derivatives incorporating isoindoline-1, 3-dione moiety as … (2024).

24 - Efficient Green Synthesis of Hydrazide Derivatives Using L-Proline: Structural Characterization, Anticancer Activity, and Molecular Docking Studies (2024).

25 - Green synthesis of hydrazono-thiazolones using vitamin B1 and their antibacterial implications (2024).

26 - Novel phthalimide-pyrimidine hybrids as potent anti-tubercular agents (2024).

27 - Synthesis, molecular docking, in silico study, and evaluation of bis-thiazole-based curcumin derivatives as potential antimicrobial agents (2024).

28 - Facile one-pot synthesis and in silico study of new heterocyclic scaffolds with 4-pyridyl moiety: Mechanistic insights and X-ray crystallographic elucidation (2024).

29 - Design and synthesis of novel hybrids incorporating thiadiazole or thiazole-naphthalene: Anticancer assessment and molecular docking study (2024).

30 - Synthesis of Bis-thiazoles Tethered 1,4-Dihydropyridine and Pyridine Linkers via Simple Oxidation and their Molecular Docking as VEGFR -TK Inhibitors (2024).

31 - Synthesis of Bis-thiazoles Tethered 1,4-Dihydropyridine and Pyridine Linkers via Simple Oxidation and their Molecular Docking as VEGFR-TK Inhibitors (2024).

32 - Green Biocatalyst for Ultrasound-Assisted Thiazole Derivatives: Synthesis, Antibacterial Evaluation, and Docking Analysis (2024).

33 - Synthesis of novel Bis-1, 2, 4-Triazolo [3, 4-b][1, 3, 4] Thiadiazines from natural camphoric acid as potential anti-candidal agents (2024).

34 - Chitosan–sulfonic acid-catalyzed green synthesis of naphthalene-based azines as potential anticancer agents (2024).

35 - Synthesis, molecular docking study, and biological evaluation and of new thiadiazole and thiazole derivatives incorporating isoindoline-1,3-dione moiety as anticancer and antimicrobial agents (2024).

36 - Cyanauric Chloride as a key precursor and a core component for Three-Armed Triazolopyrimidines: Recent finding about SARs and docking analyses (2024).

37 - Green synthesis and molecular docking study of some new thiazoles using terephthalohydrazide chitosan hydrogel as ecofriendly biopolymeric catalyst (2023).

38 - Using terephthalohydrazide chitosan hydrogel as ecofriendly biopolymeric catalyst (2023).

39 - Mechanochemical synthesis and molecular docking studies of new azines bearing indole as anticancer agents (2023).

40 - Synthesis and in vitro study of pyrimidine–phthalimide hybrids as VEGFR2 inhibitors with antiproliferative activity (2023).

41 - Design, synthesis and antitumor activity of novel pyran-functionalized uracil derivatives: docking studies (2023).

42 - Green route synthesis and molecular docking of azines using cellulose sulfuric acid under microwave irradiation (2023).

43 - Synthesis and molecular docking of some novel 3-thiazolyl-coumarins as inhibitors of VEGFR-2 kinase (2023).

44 - Novel pyrimidine derivatives: Synthesis, Molecular Docking Studies, and structure activity relationship (2023).

45 - Synthesis, Molecular Docking and Anticancer Activity of Some 5-Aryl-5,10-dihydropyrido[2,3-d:6,5-d′]dipyrimidine-2,4,6,8-tetraone Derivatives and Pyrido[2,3-d]pyrimidines (2022).

المجالات البحثية

الابحاث العلمية

تسجيل الدخول

صفحاتنا

الدعم الفنى

إتصل بنا